tirzepatide ruling 2025 FDA Announces End To Compounded By March 19, Out of Shortage, Into Controversy:

How Are These Injectables Accessed

In an interview last year, Custer admitted how easily GLP-1s can be "sort of de-blinded." He implied that asking patients to sign up for a 72-week experience where they might be randomized to a placebo could, in some cases, be gambling with their health

doi: 10.1034/j.1600-0447.2001.00405.x 4 KleinSLFlanaganKL

What matters most, though, is what the FDA label adds straight away: these hair loss reactions were linked to the weight loss, not to any direct damaging effect of the molecule on the hair root

This personalized assessment ensures you receive the care that best supports your long-term wellness, even if your BMI doesnt meet traditional criteria